A high-throughput small molecule screen identifies farrerol as a potentiator of CRISPR/Cas9-mediated genome editing

Abstract

Directly modulating the choice between homologous recombination (HR) and non-homologous end joining (NHEJ) - two independent pathways for repairing DNA double-strand breaks (DSBs) - has the potential to improve the efficiency of gene targeting by CRISPR/Cas9. Here, we have developed a rapid and easy-to-score screening approach for identifying small molecules that affect the choice between the two DSB repair pathways. Using this tool, we identified a small molecule, farrerol, that promotes HR but does not affect NHEJ. Further mechanistic studies indicate that farrerol functions through stimulating the recruitment of RAD51 to DSB sites. Importantly, we demonstrated that farrerol effectively promotes precise targeted integration in human cells, mouse cells and mouse embryos at multiple genomic loci. In addition, treating cells with farrerol did not have any obvious negative effect on genomic stability. Moreover, farrerol significantly improved the knock-in efficiency in blastocysts, and the subsequently generated knock-in mice retained the capacity for germline transmission.

Data availability

All data generated or analyzed during this study are included in the manuscript and supporting files. Source data files have been provided for Figure 1, 2, 3, 4, 5, 6 and figure supplements contained within 'Source data files'. Primer sequences named 'Table 1-source data 1' are also included as 'Source data files'.

Article and author information

Author details

  1. Weina Zhang

    School of Life Science and Technology, Tongji University, Shanghai, China
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2852-4079
  2. Yu Chen

    School of life sciences and technology, Tongji University, Shanghai, China
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9661-3914
  3. Jiaqing Yang

    School of Life Science and Technology, Tongji University, Shanghai, China
    Competing interests
    The authors declare that no competing interests exist.
  4. Jing Zhang

    School of Life Science and Technology, Tongji University, Shanghai, China
    Competing interests
    The authors declare that no competing interests exist.
  5. Jiayu Yu

    School of Life Science and Technology, Tongji University, Shanghai, China
    Competing interests
    The authors declare that no competing interests exist.
  6. Mengting Wang

    School of Life Science and Technology, Tongji University, Shanghai, China
    Competing interests
    The authors declare that no competing interests exist.
  7. Xiaodong Zhao

    School of Life Science and Technology, Tongji University, Shanghai, China
    Competing interests
    The authors declare that no competing interests exist.
  8. Ke Wei

    School of Life Science and Technology, Tongji University, Shanghai, China
    Competing interests
    The authors declare that no competing interests exist.
  9. Xiaoping Wan

    School of Life Science and Technology, Tongji University, Shanghai, China
    Competing interests
    The authors declare that no competing interests exist.
  10. Xiaojun Xu

    State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China
    Competing interests
    The authors declare that no competing interests exist.
  11. Ying Jiang

    School of Life Science and Technology, Tongji University, Shanghai, China
    Competing interests
    The authors declare that no competing interests exist.
  12. Jiayu Chen

    School of Life Science and Technology, Tongji University, Shanghai, China
    For correspondence
    chenjiayu@tongji.edu.cn
    Competing interests
    The authors declare that no competing interests exist.
  13. Shaorong Gao

    School of Life Sciences and Technology, Tongji University, Shanghai, China
    For correspondence
    gaoshaorong@tongji.edu.cn
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1041-3928
  14. Zhiyong Mao

    School of Life Science and Technology, Tongji University, Shanghai, China
    For correspondence
    zhiyong_mao@tongji.edu.cn
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5298-1918

Funding

Chinese National Program on Key Basic Research Project (2018YFC2000100)

  • Zhiyong Mao

the key project of the Science and Technology of Shanghai Municipality (19JC1415300)

  • Shaorong Gao

the Shanghai Rising-Star Program (19QA1409600)

  • Jiayu Chen

the Shanghai Municipal Medical and Health Discipline Construction Projects (2017ZZ02015)

  • Xiaoping Wan

the Young Elite Scientist Sponsorship Program by CAST (2018QNRC001)

  • Jiayu Chen

Chinese National Program on Key Basic Research Project (2017YFA010330)

  • Ying Jiang

Chinese National Program on Key Basic Research Project (2016YFA0100400)

  • Shaorong Gao

the National Science Foundation of China (31871438)

  • Zhiyong Mao

the National Science Foundation of China (81972457)

  • Ying Jiang

the National Science Foundation of China (31721003)

  • Shaorong Gao

the National Science Foundation of China (31871446)

  • Jiayu Chen

the Fundamental Research Funds for the Central Universities, Program of Shanghai Academic Research Leader (19XD1403000)

  • Zhiyong Mao

Shuguang Program" of Shanghai Education Development Foundation and Shanghai Municipal Education Commission" (19SG18)

  • Zhiyong Mao

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: The specific-pathogen-free-grade mice, including C57BL/6n, ICR, and BDF1 mice, were housed in the animal facility at Tongji University. All the mice had free access to food and water. All the experiments were performed in accordance with the University of Health Guide for the Care and Use of Laboratory Animals, and were approved by the Biological Research Ethics Committee of Tongji University, and the approved protocol number was TJLAC-019-095.

Copyright

© 2020, Zhang et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,401
    views
  • 910
    downloads
  • 26
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Weina Zhang
  2. Yu Chen
  3. Jiaqing Yang
  4. Jing Zhang
  5. Jiayu Yu
  6. Mengting Wang
  7. Xiaodong Zhao
  8. Ke Wei
  9. Xiaoping Wan
  10. Xiaojun Xu
  11. Ying Jiang
  12. Jiayu Chen
  13. Shaorong Gao
  14. Zhiyong Mao
(2020)
A high-throughput small molecule screen identifies farrerol as a potentiator of CRISPR/Cas9-mediated genome editing
eLife 9:e56008.
https://doi.org/10.7554/eLife.56008

Share this article

https://doi.org/10.7554/eLife.56008

Further reading

    1. Cell Biology
    2. Stem Cells and Regenerative Medicine
    Nathaniel Paul Meyer, Tania Singh ... Diane L Barber
    Research Article

    Our understanding of the transitions of human embryonic stem cells between distinct stages of pluripotency relies predominantly on regulation by transcriptional and epigenetic programs with limited insight on the role of established morphological changes. We report remodeling of the actin cytoskeleton of human embryonic stem cells (hESCs) as they transition from primed to naïve pluripotency which includes assembly of a ring of contractile actin filaments encapsulating colonies of naïve hESCs. Activity of the Arp2/3 complex is required for the actin ring, to establish uniform cell mechanics within naïve colonies, promote nuclear translocation of the Hippo pathway effectors YAP and TAZ, and effective transition to naïve pluripotency. RNA-sequencing analysis confirms that Arp2/3 complex activity regulates Hippo signaling in hESCs, and impaired naïve pluripotency with inhibited Arp2/3 complex activity is rescued by expressing a constitutively active, nuclear-localized YAP-S127A. Moreover, expression of YAP-S127A partially restores the actin filament fence with Arp2/3 complex inhibition, suggesting that actin filament remodeling is both upstream and downstream of YAP activity. These new findings on the cell biology of hESCs reveal a mechanism for cytoskeletal dynamics coordinating cell mechanics to regulate gene expression and facilitate transitions between pluripotency states.

    1. Cell Biology
    Xiaojiao Hua, Chen Zhao ... Yan Zhou
    Research Article

    The β-catenin-dependent canonical Wnt signaling is pivotal in organ development, tissue homeostasis, and cancer. Here, we identified an upstream enhancer of Ctnnb1 – the coding gene for β-catenin, named ieCtnnb1 (intestinal enhancer of Ctnnb1), which is crucial for intestinal homeostasis. ieCtnnb1 is predominantly active in the base of small intestinal crypts and throughout the epithelia of large intestine. Knockout of ieCtnnb1 led to a reduction in Ctnnb1 transcription, compromising the canonical Wnt signaling in intestinal crypts. Single-cell sequencing revealed that ieCtnnb1 knockout altered epithelial compositions and potentially compromised functions of small intestinal crypts. While deletion of ieCtnnb1 hampered epithelial turnovers in physiologic conditions, it prevented occurrence and progression of Wnt/β-catenin-driven colorectal cancers. Human ieCTNNB1 drove reporter gene expression in a pattern highly similar to mouse ieCtnnb1. ieCTNNB1 contains a single-nucleotide polymorphism associated with CTNNB1 expression levels in human gastrointestinal epithelia. The enhancer activity of ieCTNNB1 in colorectal cancer tissues was stronger than that in adjacent normal tissues. HNF4α and phosphorylated CREB1 were identified as key trans-factors binding to ieCTNNB1 and regulating CTNNB1 transcription. Together, these findings unveil an enhancer-dependent mechanism controlling the dosage of Wnt signaling and homeostasis in intestinal epithelia.